A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances.
Lijun ZhaoShuhong LiXiaoyi WeiXuexiu QiQiaoru GuoLicai ShiJi-Shuai ZhangJun LiZe-Lin LiuZhi GuoHongyu ZhangJia FengYuanyuan ShiSuping ZhangYu J CaoPublished in: Protein & cell (2024)
Keyphrases